Fluorescence Imaging Systems Market Revenue, Top Companies, Report 2033


17 Jul 2024

Share : linkedin twitter facebook

The global fluorescence imaging systems market revenue was valued at USD 1,055.20 million in 2023 and is poised to grow from USD 1,136.94 million in 2024 to USD 1,872.60 million by 2033, at a CAGR of 5.70% during the forecast period 2024 – 2033. The non-invasive nature of fluorescence imaging systems is influencing the growth of the market.

Fluorescence Imaging Systems Market Statistics

Market Overview

Fluorescence microscopy is considered to be the most powerful and extensively used imaging technique, which visualizes fluorescence signals released from samples with fluorescence labels or fluorophores. Fluorophores are molecules that can absorb light of a certain wavelength and re-release with a wider wavelength. It is highly used in several fields like medical diagnostics, biotechnology, molecular biology research, and drug discovery. It refers to the market concerned about generating, distributing, and studying the imaging systems that are produced by utilizing fluorescence technology.

Fluorescence imaging allows the study of specific cells or tissues by passing them through light of a specific wavelength and then detecting the fluorescence released from it. Fluorescence imaging systems are used in many sectors, like live cell screening, fluorescence cell imaging, and high-content screening. In live cell screening, fluorescence imaging is used to monitor the cells in real time and study them, which is useful for observing and understanding cellular processes and drug interactions.

High-content screening is used to analyze a huge number of samples by using fluorescence imaging to get the data on several parameters. For multiple research studies and diagnosis purposes, fluorescence cell imaging is useful. 

  • Continuous evolution in imaging technology: Regular advancements in technologies like confocal microscopy, multiphoton microscopy, and super-resolution microscopy are highly influencing the fluorescence imaging systems market. Such advancements in fluorescence imaging systems help researchers study cellular structures and function more accurately due to in-depth imaging and high resolution.
  • Rising medical diagnosis concern: The fluorescence imaging system plays an important role in the medical diagnosis of diseases like cancer and the study of several infectious diseases. Due to its high-definition visualization, the chances of accuracy in diagnosis are high as the cellular structures are visible clearly, and it helps to initiate proper medication after studying reports precisely, which, as a result, enhances the success rate of treatment.
  • Regular studies and enhancement of drug discovery: The Fluorescence imaging system market is highly accepted by pharmaceutical studies or biotechnology studies for the development of more effective treatment methods and medications. Monitoring real-time structure and changes in cells gives many ideas and helps to understand the nature of diseases, hence improving the prevention methods.

The advancement of imaging technology is driving the market

There are multiple reasons influencing the fluorescence imaging systems market, and among all of them, rapid advancement in this sector is one. With the support of several pharmaceutical and biotechnological companies for regular research studies, the development of the market is rapid and continuous in the field of drug enhancement, diagnosis techniques, etc. By introducing improved detectors and advanced software, the capabilities of the market are enhanced significantly. Growing demand for non-invasive medical imaging technology, accuracy, and improved image quality as the concern for early detection of diseases is rising among people.

Moreover, the incorporation of machine learning algorithms and artificial intelligence is improving the fluorescence imaging systems as well as interpretation imaging, which results in better treatment and medication. Government initiatives and guidelines also play an important role in influencing the fluorescence imaging systems market. Companies working in this market need to follow various guidelines to confirm the safety and efficiency of their products. Furthermore, legal factors like license agreements and intellectual property rights can influence the market.

Apart from various growth opportunities, there are several hindrances in the market. High charges are linked with fluorescence imaging systems due to maintenance and investment in research laboratories and healthcare facilities. The equipment is of high cost, and the requirement of skilled professionals and funding for research studies are creating hindrances in the growth of the fluorescence imaging systems market. The absence of acceptable compensation for fluorescence imaging systems in some areas restricts market growth. In some regions, the absence of awareness also challenges the growth of the market. This hindrance can be overcome by educating and training medical professionals.

Fluorescence Imaging Systems Market Highlights

Report Attribute Key Statistics
Market Revenue in 2024 USD 1,136.94 Million 
Market Revenue by 2033 USD 1,872.60 Million
Market CAGR 5.70% from 2024 to 2033
Quantitative Units Revenue in USD million/billion, Volume in units
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Top Companies in the Fluorescence Imaging Systems Market

  • PerkinElmer Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
  • Leica Microsystems GmbH
  • Quest Medical Imaging BV
  • Shimadzu Corporation
  • Stryker Corporation
  • Amscope
  • Euromex Microscope BV
  • CMR Surgical
  • Anmo Electronics Corporation
  • Etaluma Inc.
  • CrestOptics SpA
  • Cairn Research Ltd.
  • Edmund Optics Inc.
  • Delmic B.V.

Recent Development by CMR Surgical

  • In February 2024, CMR Surgical, which is a British medical device company, launched vLimeLite, which is an incorporated fluorescence imaging technology used to visualize ICG.

Recent Development by CrestOptics SpA

  • In April 2023, CrestOptics SpA, a leading company in the development and manufacture of advanced systems for fluorescence microscopy, launched the CICERO system, a new spinning disk confocal microscope system. This system was developed to make high-end imaging accessible to the wider scientific community.

Regional Insights

Asia-Pacific is anticipated to grow at the fastest rate during the forecast period of 2024 to 2033 due to rising healthcare infrastructure. In countries like India, Japan, South Korea, and China, the rapid expansion in the healthcare sector and biotechnology industries is driving the fluorescence imaging systems market.

North America dominated the market in 2023 due to its advanced technology and research studies. It is helpful in precisely detecting cancer cells which further helps to reduce the risk and choose suitable treatment and therapies. In April 2024, the Food and Drug Administration (FDA) approved fluorescence imaging systems to enhance the detection of residual breast cancer.

Europe region has observed markable growth in the fluorescence imaging systems market due to rising research and technological evolution. Government initiatives and funding for research studies are driving the market rapidly.

Market Potential and Growth Opportunity

Technological advancements like miniature and portable devices

Continuous innovation and enhancement in the biotechnology sector are raising the opportunities for the fluorescence imaging systems market to grow. The development of miniature and portable fluorescence imaging devices. The introduction of machine learning algorithms and artificial intelligence to the fluorescence imaging report accuracy increases which increases the opportunities. The market shows vital opportunities influenced by the progression of biotechnology, medical research, and the diagnostic field. These systems permit close visualization of molecular and cellular structures, which is important for observing disease mechanisms and medicine development.

With the increase in demand for advancement in the pharmaceutical field, life science, and clinical diagnosis market, there is a high scope for growth in the high-resolution fluorescence imaging system market. Revolutionizing technologies such as super-resolution microscopy and multiphoton imaging enlarge the probabilities in immunology, cancer research, and neuroscience. As the healthcare sector continues to evolve consistently, the scope for the growth of the fluorescence imaging systems market is increasing exponentially.

Fluorescence Imaging Systems Market News

  • In October 2023, Samvardhana Motherson International Ltd. announced 3 acquisitions valued at more than Rs. 280 Crore in aerospace, health, and medical sectors.
  • In June 2023, PerkinElmer Inc., which is a global leader who is committed to innovating for the healthcare sector, launched IVIS Lumina S5 and Lumina X5 systems for high throughput benchtop 2D optical in vivo imaging systems.
  • In October 2023, Lambert Instruments, which is a company dedicated to developing and manufacturing advanced imaging solutions, launched its camera-based Fluorescence Lifetime Imaging Microscopy (FLIM).

Market Segmentation

By Type

  • Inverted Fluorescence Microscopy
  • Upright Fluorescence Microscopy 

By Technology

  • Wide-field Imaging
  • Total Internal Reflection Fluorescence Imaging
  • Confocal Imaging

By Component

  • Equipment
  • Software Consumables

By End User

  • Research Laboratories
  • Hospitals
  • Diagnostics Centers
  • Others

Buy this Research Report@ 

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308

Related Reports